Illicit drugs
Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Searching the Web
illicit drugs classification types categories WHO DEA 2024 2025
Reading File
I now have comprehensive information from both the textbook (P C Dikshit Textbook of Forensic Medicine and Toxicology) and current web sources. Let me compile a thorough, well-organized response.
Classification of Illicit Drugs
Illicit drugs are substances whose manufacture, distribution, or possession is prohibited or strictly regulated by law due to their abuse potential, lack of accepted medical use (or restricted medical use), and harm to individuals and society. Below is a structured breakdown of how they are classified.
1. Pharmacological / CNS-Effect Classification
The most widely used medical classification groups drugs by their primary effect on the central nervous system:
A. CNS Depressants
Slow brain activity; produce sedation, relaxation, and at high doses, unconsciousness or death.
- Opioids/Narcotics - Heroin, opium, morphine, fentanyl, pethidine. Most addictive category with severe physical dependence and life-threatening withdrawal.
- Barbiturates - Phenobarbital, secobarbital ("sleepers," "goof balls"). Strong tolerance and cross-tolerance; withdrawal can be fatal within 2-3 days.
- Benzodiazepines - Diazepam, alprazolam (when misused). Tolerance develops; postural hypotension characteristic.
- Alcohol - Ethanol and alcohol-containing beverages (legally available but biologically a CNS depressant/drug of abuse).
B. CNS Stimulants
Increase alertness, heart rate, blood pressure; produce euphoria and wakefulness.
- Amphetamines - Methamphetamine, MDMA/Ecstasy, cathinones (Khat). Street names: "Purple Hurts," "Black bombers," "pep pills." Cause psychic dependence and toxic psychosis with prolonged use.
- Cocaine - Derived from coca leaves; snorted, smoked (crack), or injected. Unique: produces no physical tolerance and no withdrawal syndrome, but strong psychological dependence.
- Ephedrine, Benzedrine - Milder stimulants with abuse potential.
C. Hallucinogens / Psychedelics
Distort perception, thought, and emotion; do not typically cause physical dependence.
- Cannabis (Marijuana, Charas, Ganja, Hashish) - Most widely used illicit drug globally. THC is the active component. No tolerance, no withdrawal symptoms, no desire to escalate dose (cannabis-type dependence per WHO).
- LSD (Lysergic acid diethylamide) - Extremely potent; 25-50 mcg produces full hallucinations.
- Mescaline - Derived from the peyote cactus.
- Psilocybin ("magic mushrooms")
- Phencyclidine (PCP, "angel dust")
- Methaqualone (Mandrax) - Also has sedative properties; classified here due to euphoric/hallucinogenic misuse.
D. Dissociatives
- Ketamine - Medical anesthetic abused for dissociative/hallucinogenic effects.
- PCP (Phencyclidine) - Also fits here.
E. Deliriants
Cause confusion and toxic delirium at abused doses.
- Anticholinergics (e.g., atropine, scopolamine abuse), certain plant toxins, solvents.
F. Inhalants / Hydrocarbons
- Glue, paint thinner, aerosols, nitrous oxide. Cheap and accessible; disproportionately abused by adolescents.
G. Hypnotics
- Barbiturate group - Overlaps with depressants; taken for sleep induction/escape.
2. WHO's 5 Types of Dependence
The WHO classifies drug dependence by pattern and severity (as cited in P C Dikshit Textbook of Forensic Medicine and Toxicology, p. 551):
| Type | Craving | Tolerance | Withdrawal | Psychic Dependence |
|---|---|---|---|---|
| Morphine-type (opioids) | Overpowering | Yes | Yes (hours after cessation; arrhythmia risk) | Yes |
| Barbiturate-type | Strong | Yes | Yes (peak 2-3 days; cross-tolerance) | Yes |
| Cocaine-type | Present | No | No | Yes |
| Cannabis-type | Mild | No | No | Minimal |
| Amphetamine-type | Increasing | Yes | No abstinence syndrome | Yes (toxic psychosis) |
3. Legal / Regulatory Classification (DEA Schedule, USA)
Under the US Controlled Substances Act (1970), drugs are placed into five schedules based on medical use and abuse potential:
| Schedule | Criteria | Examples |
|---|---|---|
| I | No accepted medical use; high abuse potential | Heroin, LSD, MDMA/Ecstasy, peyote, marijuana* |
| II | Accepted medical use with severe restrictions; high abuse potential | Cocaine, fentanyl, methamphetamine, oxycodone |
| III | Moderate-to-low dependence potential; accepted medical use | Anabolic steroids, ketamine, codeine (<900 ml/dose) |
| IV | Low abuse potential; accepted medical use | Benzodiazepines (alprazolam), muscle relaxants |
| V | Minimal abuse potential | Cough syrups with low-dose codeine |
Note: As of July 2026, marijuana remains Schedule I despite a DOJ proposal (May 2024) to reschedule it to Schedule III. Hearings were held in early 2025 but the DEA has not yet finalized rescheduling, per MedShadow Foundation.
4. "Hard" vs. "Soft" Drugs (Lay/Forensic Classification)
As described in forensic medicine literature (P C Dikshit Textbook of Forensic Medicine and Toxicology, p. 551):
- Hard drugs (Narcotics) - Opioids (heroin, morphine, opium). Severe physical and psychological dependence; high mortality risk from overdose.
- Soft drugs (Non-narcotics) - Cannabis, mild stimulants. Lower dependence severity, though "soft" does not mean "safe."
5. Routes of Administration (affects classification of abuse risk)
- Oral - Slowest onset; muted CNS impact (e.g., cannabis edibles, pills).
- Inhalation/Smoking - Fast absorption (e.g., crack cocaine, cannabis, methamphetamine).
- Snorting - Cocaine powder, crushed pills.
- Injection (IV "mainlining") - Fastest onset; highest overdose risk. IV opioids produce a euphoric "rush" lasting 45-50 seconds.
- Skin-popping (subcutaneous) - Common with heroin; risk of abscesses and infection.
6. Emerging/New Psychoactive Substances (NPS)
Per the UNODC World Drug Report 2025, the synthetic drug market continues to expand globally:
- Synthetic opioids - Fentanyl, nitazenes (e.g., etonitazene - up to 500x more potent than heroin).
- Synthetic cannabinoids - "Spice," "K2."
- Cathinones ("bath salts") - Synthetic stimulants.
- Captagon - Illicitly manufactured amphetamine; major problem in Middle East/Gulf region.
Quick Reference Summary
| Category | Key Drugs | Primary Risk |
|---|---|---|
| Opioids | Heroin, fentanyl, opium | Overdose death, severe dependence |
| Stimulants | Cocaine, meth, MDMA | Cardiac events, psychosis |
| Cannabis | Marijuana, hashish | Psychological dependence, cognitive effects |
| Hallucinogens | LSD, mescaline, psilocybin | Perceptual disturbances, flashbacks |
| Depressants | Barbiturates, GHB | Respiratory depression, fatal withdrawal |
| Dissociatives | Ketamine, PCP | Dissociation, psychosis |
| Inhalants | Solvents, aerosols | Sudden sniffing death, organ damage |
| NPS | Synthetic opioids, cathinones | Extreme potency, unpredictable effects |
Source: P C Dikshit Textbook of Forensic Medicine and Toxicology, pp. 550-553 (Classification of Drugs of Abuse, WHO Dependence Types); DEA Controlled Substances Act schedules; UNODC World Drug Report 2025.
This is a shared conversation. Sign in to Orris to start your own chat.